Stimulant-Related Disorders: Types, Symptoms & Treatment

Stimulant-related disorders involve the misuse of amphetamines (e.g., Adderall, methamphetamine), cocaine, and other stimulants, leading to addiction, psychosis, and severe health risks. The DSM-5 categorizes these disorders into:

1. Stimulant Use Disorder

DSM-5 Criteria (≥2 symptoms within 12 months)

  • Impaired Control: Using more/longer than intended.
  • Cravings: Intense urges to use stimulants.
  • Tolerance: Needing larger doses for the same effect.
  • Withdrawal: Fatigue, depression, increased appetite when stopping.
  • Neglected Responsibilities: Work, school, or relationships suffer.
  • Continued Use Despite Harm: Heart problems, psychosis, legal issues.

Severity Levels:

  • Mild (2–3 symptoms)
  • Moderate (4–5 symptoms)
  • Severe (6+ symptoms)

High-Risk Groups:

  • Students misusing ADHD meds (e.g., Adderall for studying).
  • Methamphetamine/cocaine users (higher addiction potential).

2. Stimulant Intoxication

Symptoms:

  • Euphoria, hyperactivity, talkativeness.
  • Increased heart rate, high blood pressure (risk of stroke/heart attack).
  • Paranoia, aggression, hallucinations (high doses).

Overdose Signs:

  • Chest pain, seizures, hyperthermia (fatal overheating).
  • Psychotic episodes (“meth psychosis”).

Treatment:

  • Emergency care (cooling for hyperthermia, benzodiazepines for agitation).

3. Stimulant Withdrawal

Symptoms (Begins within hours–days after last use):

  • Crash Phase (First 1–3 days): Extreme fatigue, depression, excessive sleep.
  • Withdrawal Phase (Days–Weeks): Anxiety, irritability, strong cravings.
  • Protracted Symptoms (Months): Anhedonia (inability to feel pleasure), poor concentration.

Treatment:

  • Supportive care (hydration, rest).
  • Antidepressants (if severe depression persists).

4. Stimulant-Induced Disorders

  • Psychotic Disorder: Paranoia, delusions, hallucinations (resembles schizophrenia).
  • Mood/Anxiety Disorders: Severe depression or panic attacks.
  • Cognitive Deficits: Memory loss, impaired decision-making (chronic meth use).

Long-Term Risks:

  • Heart disease, stroke, dental decay (“meth mouth”).
  • Neurotoxicity (brain damage from chronic use).

Treatment Options

1. Behavioral Therapies

  • Cognitive Behavioral Therapy (CBT): Identify triggers, develop coping strategies.
  • Contingency Management: Reward-based abstinence programs.
  • Matrix Model (for meth addiction): Intensive outpatient program.

2. Medications (Limited Options)

  • Bupropion or Modafinil: May reduce cravings (off-label).
  • Antipsychotics (short-term): For stimulant-induced psychosis.

3. Harm Reduction

  • Avoid binges (prevents overdose/psychosis).
  • Fentanyl test strips (cocaine is often contaminated).

When to Seek Help

✔ Using stimulants to function (e.g., work, study).
✔ Experiencing paranoia, hallucinations, or chest pain.
✔ Failed attempts to quit despite health/job problems.

Emergency Situations:

  • Overdose (seizures, chest pain, unconsciousness).
  • Severe psychosis (self-harm or violence risk).